Google News

FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide  Johnson & JohnsonJ&J wins approval for first-of-its-kind psoriasis pill | STAT  statnews.comUS FDA approves J&J's oral psoriasis pill  ReutersJ&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval  Fierce PharmaJ&J’s psoriasis pill to rival AbbVie’s Skyrizi (JNJ:NYSE)  Seeking Alpha